Skip to Content

WATSON 409 (Lisinopril 40 mg)

Pill with imprint WATSON 409 is Yellow, Round and has been identified as Lisinopril 40 mg. It is supplied by Watson Pharmaceuticals.

Lisinopril is used in the treatment of diabetic kidney disease; heart attack; high blood pressure; heart failure and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 40 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 409

Lisinopril 40 mg WATSON 409
Lisinopril 40 mg WATSON 409  Front
Lisinopril 40 mg WATSON 409  Back
Lisinopril 40 mg WATSON 409
Lisinopril 40 mg WATSON 409

Lisinopril

Imprint
WATSON 409
Strength
40 mg
Color
Yellow
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Angiotensin Converting Enzyme Inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
Inactive Ingredients
silicon dioxide, calcium phosphate dihydrate dibasic, FD&C Yellow No. 5, magnesium stearate, mannitol, corn starch

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00591-0409 Watson Pharmaceuticals, Inc.
54868-4646 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.